| Autor: |
Mantovani, Giovanni, Anker, Stefan D., Inui, Akio, Morley, John E., Scevola, Daniele, Schuster, Michael W., Shing-Shing Yeh, Laviano, Alessandro, Cascino, Antonia, Meguid, Michael M., Preziosa, Isabella, Fanelli, Filippo Rossi |
| Zdroj: |
Cachexia & Wasting: A Modern Approach; 2006, p635-641, 7p |
| Abstrakt: |
Cachexia is pervasive among patients suffering from chronic diseases, including cancer, liver cirrhosis and chronic renal failure. The development of cachexia dramatically impacts on the clinical course of the underlying disease, by increasing morbidity and mortality, and impinging on patients' quality of life. Also, weight loss influences outcome by increasing drug-induced toxicity and impeding completion of the therapeutic schedule. Particularly in cancer patients, weight loss is a reliable predictor for toxicity from treatment and shorter survival [1]. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
